Riot Platforms continues to acquire shares while responding to Bitfarms’ “poison pill” strategy. Bitfarms recently initiated a defensive measure to prevent any company from acquiring more than 15% of its shares from June 20 to September 10. Riot Platforms CEO criticized Bitfarms’ approach, labeling it as divergent from conventional business practices. Riot Platforms persists in